Showing 21 - 40 results of 933 for search '"virology"', query time: 0.07s Refine Results
  1. 21
  2. 22
  3. 23
  4. 24
  5. 25

    Short Term Virologic Efficacies of Telbivudine versus Entecavir against Hepatitis B-Related Hepatocellular Carcinoma by Young Woon Kim, Jung Hyun Kwon, Eun Chung, Sung Won Lee, Jong-yul Lee, Jeong Won Jang, Kyu Won Chung, Soon Woo Nam

    Published 2015-01-01
    “…We investigated the short term virologic efficacy of TLV in comparison with ETV as the first-line agent of HBV suppression in HBV-related advanced HCC patients. …”
    Get full text
    Article
  6. 26
  7. 27

    Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients by Glenn Wagner, Karen Chan Osilla, Jeffrey Garnett, Bonnie Ghosh-Dastidar, Laveeza Bhatti, Matthew Bidwell Goetz, Mallory Witt

    Published 2011-01-01
    “…Chart abstracted and survey data were collected on 72 HIV patients who had received pegylated interferon and ribavirin to assess correlates of treatment adherence, completion, and sustained virologic response (SVR). Results. Nearly half (46%) the sample had active psychiatric problems and 13% had illicit drug use at treatment onset; 28% reported <100% treatment adherence, 38% did not complete treatment (mostly due to virologic nonresponse), and intent to treat SVR rate was 49%. …”
    Get full text
    Article
  8. 28

    Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients by Ioannis S. Elefsiniotis, Christos Pavlidis, Elena Vezali, Theodoros Mariolis-Sapsakos, Sotirios Koutsounas, George Saroglou

    Published 2009-01-01
    “…To evaluate the impact of hepatitis B core antibody (anti-HBc) seropositivity in sustained virological response (SVR) rates in treatment-naïve, chronic hepatitis C (CHC) patients with high pretreatment viral load (>800000 IU/mL). …”
    Get full text
    Article
  9. 29
  10. 30

    Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy by Catherine Orrell, Richard Kaplan, Robin Wood, Linda-Gail Bekker

    Published 2011-01-01
    “…While 67% of those who experience initial virological breakthrough resuppress after an adherence intervention, these individuals are significantly less likely be retained in care than those who remain virologically suppressed throughout.…”
    Get full text
    Article
  11. 31
  12. 32

    Comparative Analysis of Virology and Pathogenesis of SARS-CoV-2 and HIV Infections: Implications for Public Health and Treatment Strategies by Olebo DF, Igwe MC

    Published 2025-01-01
    “…Understanding their differences can enhance public health strategies and treatment approaches.Purpose: This narrative review compares the virology, transmission, immune responses, and clinical outcomes of SARS-CoV-2 and HIV to inform treatment strategies and public health interventions.Methods: A narrative review was conducted, synthesizing data from peer-reviewed literature and expert commentary from 2010 to 2024. …”
    Get full text
    Article
  13. 33
  14. 34
  15. 35

    Virological outcomes of antiretroviral therapy and its determinants among HIV patients in Ethiopia: Implications for achieving the 95-95-95 target. by Tegene Atamenta Kitaw, Ribka Nigatu Haile

    Published 2025-01-01
    “…<h4>Background</h4>Despite significant advancements in HIV treatment, virological outcomes remain a critical issue. Ethiopia did not meet the 90:90:90 targets set for 2020, which aimed for 90% of people on antiretroviral therapy to achieve viral suppression. …”
    Get full text
    Article
  16. 36
  17. 37
  18. 38
  19. 39
  20. 40